Inventor
DUPORTET XAVIER
FR22 patents
⚠️ This page may combine multiple inventors who share the name “DUPORTET XAVIER”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ELIGO BIOSCIENCE
20 patentsUS11541106B2Jan 3, 2023
Method for killing bacteria with an engineered postbiotic
ELIGO BIOSCIENCE7 citations85
US10808254B2Oct 20, 2020
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE4 citations83
US11224621B2Jan 18, 2022
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE4 citations81
US11633348B2Apr 25, 2023
Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
ELIGO BIOSCIENCE4 citations74
US11839645B2Dec 12, 2023
Therapeutic use of engineered postbiotics comprising bacteriocins and/or endolysins
ELIGO BIOSCIENCE1 citations72
US11746352B2Sep 5, 2023
Microbiome modulation of a host by delivery of DNA payloads with minimized spread
ELIGO BIOSCIENCE3 citations72
US11078490B2Aug 3, 2021
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE3 citations72
US11690880B2Jul 4, 2023
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE3 citations70
US11534467B2Dec 27, 2022
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE1 citations70
US11124776B2Sep 21, 2021
Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
ELIGO BIOSCIENCE2 citations69
US11376286B2Jul 5, 2022
Modulation of microbiota function by gene therapy of the microbiome to prevent, treat or cure microbiome-associated diseases or disorders
ELIGO BIOSCIENCE1 citations67
US12214070B2Feb 4, 2025
Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
ELIGO BIOSCIENCE0 citations62
US12098372B2Sep 24, 2024
Microbiome modulation of a host by delivery of DNA payloads with minimized spread
ELIGO BIOSCIENCE0 citations62
US11946056B2Apr 2, 2024
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE0 citations62
US11905516B2Feb 20, 2024
Optimized vector for delivery in microbial populations
ELIGO BIOSCIENCE0 citations62
US11584781B2Feb 21, 2023
Chimeric receptor binding proteins resistant to proteolytic degradation
ELIGO BIOSCIENCE0 citations62
US11952594B2Apr 9, 2024
Pharmaceutical compositions comprising bacterial delivery vehicles and uses thereof
ELIGO BIOSCIENCE0 citations59
US11617773B2Apr 4, 2023
Elimination of colonic bacterial driving lethal inflammatory cardiomyopathy
ELIGO BIOSCIENCE0 citations58
US11970716B2Apr 30, 2024
Transcriptional control in prokaryotic cells using DNA-binding repressors
ELIGO BIOSCIENCE0 citations57
US11584918B2Feb 21, 2023
Transcriptional control in prokaryotic cells using DNA-binding repressors
ELIGO BIOSCIENCE1 citations57